Chromium picolinate
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Chromium picolinate
- DrugBank Accession Number
- DB11255
- Background
Chromium picolinate has a chemical formula CrPic3 and reddish-pink color. It is a coordination complex consisting of chromium(III) and picolinic acid. Chromium picolinate is used as a nutritional supplement for optimal insulin function in patients with Type 2 diabetes or promotion of weight loss. Chromium ions are shown to regulate insulin by promoting glucose utilization and increasing the sensitivity of the insulin receptor 1.
- Type
- Small Molecule
- Groups
- Approved
- Structure
- Weight
- Average: 418.3005
Monoisotopic: 418.013122035 - Chemical Formula
- C18H12CrN3O6
- Synonyms
- Chromium(III) picolinate
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Therapies
- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareBetibeglogene autotemcel The risk or severity of adverse effects can be increased when Chromium picolinate is combined with Betibeglogene autotemcel. Exagamglogene autotemcel The risk or severity of myelosuppression can be increased when Exagamglogene autotemcel is combined with Chromium picolinate. - Food Interactions
- Administer vitamin supplements. Foods or supplements containing niacin (Vitamin B3) may improve the absorption of chromium.
- Take with foods containing vitamin C. Foods rich in vitamin C increase the absorption of chromium.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Active Moieties
Name Kind UNII CAS InChI Key Chromium unknown 0R0008Q3JB 7440-47-3 VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromic cation ionic X1N4508KF1 16065-83-1 BFGKITSFLPAWGI-UHFFFAOYSA-N - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image ActiveLife ALA Plus Capsule Chromium picolinate (0.2 mg) + Folic acid (0.5 mg) + Lipoic acid (150 mg) + Mecobalamin (0.15 mg) + Niacin (10 mg) + Pyridoxine hydrochloride (60 mg) + Riboflavin (3.5 mg) + Thiamine hydrochloride (60 mg) Capsule Oral HS Health Serve Sdn. Bhd. 2020-09-08 2020-12-17 Malaysia BLACKMORES teen multi for GUYS capsule Chromium picolinate (282 mcg) + Ascorbic acid (40 mg) + Biotin (25 mcg) + Calcium carbonate (12.5 mg) + Cholecalciferol (5 mcg) + Cyanocobalamin (2 mcg) + Ferrous fumarate (15.7 mg) + Fish oil (420 mg) + Folic acid (200 mcg) + Magnesium (53 mg) + Nicotinamide (1 mg) + Calcium pantothenate (6 mg) + Potassium Iodide (197 mcg) + Pyridoxine hydrochloride (1.3 mg) + Riboflavin (1.3 mg) + Selenium (50 mcg) + Thiamine mononitrate (1.48 mg) + Vitamin A palmitate (1.29 mg) + Vitamin E (15 IU) + Zinc (15 mg) Capsule Oral BLACKMORES (MALAYSIA) SDN. BHD. 2020-09-08 2024-02-24 Malaysia GNC Lecithin 1200 Plus softgel Capsule Chromium picolinate (100 mcg) + Lecithin (1200 mg) Capsule Oral GNC LIVEWELL MALAYSIA SDN. BHD. 2020-09-08 Not applicable Malaysia MENOPACE KAPSUL, 30 ADET Chromium picolinate (50 mcg) + Aminobenzoic acid (30 mg) + Ascorbic acid (45 mg) + Biotin (30 mcg) + Boron (2 mg) + Copper (1 mg) + Cyanocobalamin (9 mcg) + Folic acid (400 mcg) + Iodine (225 mcg) + Iron (12 mg) + Magnesium (100 mg) + Manganese cation (2 mg) + Niacin (20 mg) + Pantothenic acid (30 mg) + Pyridoxine (40 mg) + Riboflavin (5 mg) + Selenium (100 mcg) + Thiamine (10 mg) + Vitamin A (750 mcg) + Vitamin D (2.5 mcg) + Vitamin E (30 mg) + Zinc (15 mg) Capsule Oral NOBEL İLAÇ SAN. VE TİC. A.Ş. 1999-07-22 2020-05-28 Turkey SEVEN SEAS CHROMIUM ACE SELENIUM PLUS TABLET Chromium picolinate (50 mcg) + Ascorbic acid (100 mg) + Cyanocobalamin (5 mcg) + Folic acid (400 mcg) + Magnesium (87.5 mg) + Pyridoxine hydrochloride (5 mg) + Selenium (70 mcg) + Thiamine mononitrate (5 mg) + Vitamin A (3300 IU) + Vitamin E (100 IU) + Zinc (15 mg) Tablet, film coated Oral Merck Ltd. 2020-09-08 2021-12-12 Malaysia - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Divista Chromium picolinate (1000 ug/1) + Biotin (2 mg/1) + Cyanocobalamin (15 ug/1) + Folic acid (1 mg/1) + Omega-3-acid ethyl esters (300 mg/1) + Pyridoxine (25 mg/1) Capsule Oral U.S. Pharmaceuticals 2010-07-10 2011-09-30 US Medi-10 Chromium picolinate (1 mg/1) + Acetylcysteine (200 mg/1) + Cholecalciferol (1000 [iU]/1) + Levomefolate calcium (2.5 mg/1) + Lipoic acid (200 mg/1) + Mecobalamin (2.5 mg/1) + Nicotinamide (10 mg/1) + Pyridoxal phosphate (20 mg/1) + Resveratrol (83 mg/1) + Ubidecarenone (16 mg/1) Capsule Oral Medicap Laboratories Inc. 2015-05-01 2016-01-12 US RE FAC-x Chromium picolinate (200 ug/1) + Ascorbic acid (200 mg/1) + Biotin (200 ug/1) + Cholecalciferol (400 [iU]/1) + Cupric sulfate pentahydrate (2.5 mg/1) + Cyanocobalamin (2500 ug/1) + Folic acid (2800 ug/1) + Lutein (500 ug/1) + Lycopene (500 ug/1) + Magnesium (100 mg/1) + Manganese sulfate (2.5 mg/1) + Nicotinamide (100 mg/1) + Calcium pantothenate (10 mg/1) + Pyridoxine hydrochloride (25 mg/1) + Riboflavin (20 mg/1) + Selenomethionine (100 ug/1) + Thiamine mononitrate (20 mg/1) + Vitamin A (5000 [iU]/1) + Vitamin E (100 [iU]/1) + Zinc (15 mg/1) Tablet Oral River's Edge Pharmaceuticals, LLC 2007-07-01 2011-01-13 US Vita-Rx Diabetic Vitamin Chromium picolinate (0.465 mg/1) + Ascorbic acid (120 mg/1) + Biotin (2.5 mg/1) + Cholecalciferol (0.0625 mg/1) + Folic acid (0.8 mg/1) + Lipoic acid (150 mg/1) + Mecobalamin (0.0025 mg/1) + Niacin (20 mg/1) + Calcium pantothenate (10 mg/1) + Pyridoxal phosphate (12.5 mg/1) + Riboflavin (1.7 mg/1) + Thiamine mononitrate (1.5 mg/1) + Ubidecarenone (50 mg/1) + alpha-Tocopherol acetate (10 mg/1) Capsule, gelatin coated Oral Pure Source, Llc 2015-08-11 Not applicable US Vita-Rx Diabetic Vitamin Chromium picolinate (0.465 mg/1) + Ascorbic acid (120 mg/1) + Biotin (2.5 mg/1) + Cholecalciferol (0.0625 mg/1) + Folic acid (0.8 mg/1) + Lipoic acid (150 mg/1) + Mecobalamin (0.0025 mg/1) + Niacin (20 mg/1) + Calcium pantothenate (10 mg/1) + Pyridoxal phosphate (12.5 mg/1) + Riboflavin (1.7 mg/1) + Thiamine mononitrate (1.5 mg/1) + Ubidecarenone (50 mg/1) + alpha-Tocopherol acetate (10 mg/1) Capsule, gelatin coated Oral Mas Management Group, Inc. 2015-08-11 Not applicable US
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as pyridinecarboxylic acids. These are compounds containing a pyridine ring bearing a carboxylic acid group.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Pyridines and derivatives
- Sub Class
- Pyridinecarboxylic acids and derivatives
- Direct Parent
- Pyridinecarboxylic acids
- Alternative Parents
- Heteroaromatic compounds / Carboxylic acid salts / Monocarboxylic acids and derivatives / Carboxylic acids / Azacyclic compounds / Organopnictogen compounds / Organooxygen compounds / Organonitrogen compounds / Organic zwitterions / Organic oxides show 2 more
- Substituents
- Aromatic heteromonocyclic compound / Azacycle / Carboxylic acid / Carboxylic acid derivative / Carboxylic acid salt / Heteroaromatic compound / Hydrocarbon derivative / Monocarboxylic acid or derivatives / Organic chromium salt / Organic nitrogen compound show 9 more
- Molecular Framework
- Not Available
- External Descriptors
- chromium coordination entity (CHEBI:50369)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- S71T8B8Z6P
- CAS number
- 14639-25-9
- InChI Key
- CBDQOLKNTOMMTL-UHFFFAOYSA-K
- InChI
- InChI=1S/3C6H5NO2.Cr/c3*8-6(9)5-3-1-2-4-7-5;/h3*1-4H,(H,8,9);/q;;;+3/p-3
- IUPAC Name
- chromium(3+) tris(pyridine-2-carboxylate)
- SMILES
- [Cr+3].[O-]C(=O)C1=NC=CC=C1.[O-]C(=O)C1=NC=CC=C1.[O-]C(=O)C1=NC=CC=C1
References
- General References
- Broadhurst CL, Domenico P: Clinical studies on chromium picolinate supplementation in diabetes mellitus--a review. Diabetes Technol Ther. 2006 Dec;8(6):677-87. [Article]
- External Links
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample dataNot Available Completed Prevention Atypical Depression / Obesity 1 somestatus stop reason just information to hide Not Available Completed Treatment Impaired Glucose Tolerance / Metabolic Diseases / Obesity / Resistance, Insulin / Syndrome, Metabolic 1 somestatus stop reason just information to hide Not Available Completed Treatment Type 2 Diabetes Mellitus 2 somestatus stop reason just information to hide 4 Completed Treatment Type 2 Diabetes Mellitus 1 somestatus stop reason just information to hide 1 Terminated Treatment Type 2 Diabetes Mellitus 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Tablet, coated Oral Capsule Oral Tablet Oral Tablet, film coated Oral Capsule, gelatin coated Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0312 mg/mL ALOGPS logP 2.9 ALOGPS logP -0.65 Chemaxon logS -4.1 ALOGPS pKa (Strongest Acidic) 1 Chemaxon pKa (Strongest Basic) 5.52 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 53.02 Å2 Chemaxon Rotatable Bond Count 3 Chemaxon Refractivity 41.62 m3·mol-1 Chemaxon Polarizability 10.94 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 120.8559436 predictedDarkChem Lite v0.1.0 [M+H]+ 121.3658436 predictedDarkChem Lite v0.1.0 [M+Na]+ 121.1226436 predictedDarkChem Lite v0.1.0
Drug created at December 03, 2015 16:51 / Updated at September 28, 2023 05:40